Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients
2017 · BMC Cancer · 262 citations
https://doi.org/10.1186/s12885-017-3737-z
A
Andreas W. Berger
Universität Ulm(DE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
62
Papers
1.1K
Citations
13
h-index
17
i10-index
Andreas W. Berger is an academic researcher from Universität Ulm. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Pancreatic and Hepatic Oncology Research & Colorectal Cancer Treatments and Studies. The author has an h-index of 13, co-authored 53 publications.
ORCID: 0000-0001-9862-7730Papers by this author
worksGenotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information
2019 · Scientific Reports · 106 citations
https://doi.org/10.1038/s41598-019-49860-0
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group
2018 · BMC Cancer · 75 citations
https://doi.org/10.1186/s12885-018-5183-y
Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study
2019 · BMC Cancer · 22 citations
https://doi.org/10.1186/s12885-019-6142-y
Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315)
2024 · Journal of Clinical Oncology · 12 citations
https://doi.org/10.1200/jco.23.01566
<i>KRAS</i> and <i>GNAS</i> mutations in cell‐free <scp>DNA</scp> and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms—an observational pilot study
2024 · Molecular Oncology · 3 citations
https://doi.org/10.1002/1878-0261.13719
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat